Abstract
Mutations in mitofusin-2 (MFN2) are the most common cause of axonal Charcot–Marie–Tooth (CMT) neuropathy. Herein, we report a novel double mutation in cis (c.[474+4A>G; 668T>A]) in a Korean family with late-onset autosomal dominant mild axonal CMT. Transcriptional analysis demonstrated aberrant splicing with exon 5 skipping and premature termination of translation before the missense mutation in exon 7. Interestingly, the aberrant splicing was incomplete, with some of the primary transcripts being spliced correctly and expressing the downstream missense mutation. The pathogenic relevance of the missense mutation would not be appreciated without the leaky aberrant splicing and the insensitivity of MFN2 to haploinsufficiency.
This is a preview of subscription content, log in via an institution to check access.
References
Pareyson D, Marchesi C (2009) Diagnosis, natural history, and management of Charcot–Marie–Tooth disease. Lancet Neurol 8:654–667. doi:10.1016/S1474-4422(09)70110-3
Zuchner S, Mersiyanova IV, Muglia M et al (2004) Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot–Marie–Tooth neuropathy type 2A. Nat Genet 36:449–451. doi:10.1038/ng1341
Verhoeven K, Claeys KG, Zuchner S et al (2006) MFN2 mutation distribution and genotype/phenotype correlation in Charcot–Marie–Tooth type 2. Brain 129:2093–2102. doi:10.1093/brain/awl126
Chung KW, Kim SB, Park KD et al (2006) Early onset severe and late-onset mild Charcot–Marie–Tooth disease with mitofusin 2 (MFN2) mutations. Brain 129:2103–2118. doi:10.1093/brain/awl174
Calvo J, Funalot B, Ouvrier RA et al (2009) Genotype–phenotype correlations in Charcot–Marie–Tooth disease type 2 caused by mitofusin 2 mutations. Arch Neurol 66:1511–1516
Brockmann K, Dreha-Kulaczewski S, Dechent P et al (2008) Cerebral involvement in axonal Charcot–Marie–Tooth neuropathy caused by mitofusin2 mutations. J Neurol 255:1049–1058. doi:10.1007/s00415-008-0847-1
Boaretto F, Vettori A, Casarin A et al (2010) Severe CMT type 2 with fatal encephalopathy associated with a novel MFN2 splicing mutation. Neurology 74:1919–1921
Polke JM, Laura M, Pareyson D et al (2011) Recessive axonal Charcot–Marie–Tooth disease due to compound heterozygous mitofusin 2 mutations. Neurology 77:168–173
Nicholson GA, Magdelaine C, Zhu D et al (2008) Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations. Neurology 70(19):1678–1681
Kijima K, Numakura C, Izumino H et al (2005) Mitochondrial GTPase mitofusin 2 mutation in Charcot–Marie–Tooth neuropathy type 2A. Hum Genet 116:23–27. doi:10.1007/s00439-004-1199-2
Chen H, Detmer SA, Ewald AJ et al (2003) Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 2003(160):189–200
Chen JM, Ferec C, Cooper DN (2009) Closely spaced multiple mutations as potential signatures of transient hypermutability in human genes. Hum Mutat 30:1435–1448. doi:10.1002/humu.21088
Cooper DN, Chen JM, Ball EV et al (2010) Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics. Hum Mutat 31:631–655. doi:10.1002/humu.21260
Shy ME, Blake J, Krajewski K et al (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64:1209–1214
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Su-Yeon Park and So Yeon Kim contributed equally to this article.
Rights and permissions
About this article
Cite this article
Park, SY., Kim, S.Y., Hong, YH. et al. A novel double mutation in cis in MFN2 causes Charcot–Marie–Tooth neuropathy type 2A. Neurogenetics 13, 275–280 (2012). https://doi.org/10.1007/s10048-012-0327-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10048-012-0327-8